Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro

Merck and Wellcome-backed Hilleman will manufacture Bundibugyo Ebola vaccine doses for clinical tria

SALT LAKE CITY, July 30, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the C

Gainers Autonomix Medical (NASDAQ:AMIX) shares increased by 89.4% to $5.21 during Wednesday's r

Company also completes proof of concept for the first blood-borne test for Ebola on Co-Dx PCR Pro ®

Forte Biosciences shares rose 38.9% to $76.10 in pre-market trading after argenx SE announced plans

PCR Pro Instruments and MTB Test Kits Now Deployed to Select Labs Across India SALT LAKE CITY, July

SALT LAKE CITY, July 16, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the C

Invited by the Stop TB Partnership and the Global Fund to participate as a manufacturer partner Work

More than 1,400 patients enrolled across 9 clinical sites; analytical performance testing included 2

Expansion coincides with Co-Dx webinar for prospective mosquito abatement district customers in hono

Longstanding distribution partner to support future deployment of Co-Dx™ PCR Pro ® and expanding men

https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/

Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regio

A structural shift is underway in the biodefense landscape. The declaration of a Public Health Emerg

Joint development strategy has been developed to address international deployment requirements if cu

Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, COD

SALT LAKE CITY, May 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "C

Recent pathogens illustrate need for improved situational awareness capabilities, such as those prov

https://www.cdc.gov/ebola/situation-summary/index.html

Co-Diagnostics, Inc. (CODX) Q1 2026 Earnings Call Transcript

Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion Executi

Lease execution highlights transition from approval to development and advances localized manufactur

SALT LAKE CITY, April 30, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the

MTB test on Co-Dx PCR platform* to be presented at roundtable with Stop TB Partnership, U.S. Departm

Company to engage with global customers and distributors while expanding international commercial re

U.S. stocks traded lower, with Dow falling over 100 points. Energy shares climbed 1%, while consumer

Dow falls 100+ points, S&P 500 and NASDAQ also down. Energy sector sees gains, consumer discreti

Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint v